Paradigm Biopharmaceuticals Limited (PAR.AX)
AUD 0.32
(3.23%)
AUD 0.32
(3.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -17.58 Million AUD | 68.6% |
| 2023 | -55.99 Million AUD | -43.36% |
| 2022 | -39.05 Million AUD | 44.43% |
| 2021 | -70.28 Million AUD | 31.8% |
| 2020 | -103.04 Million AUD | -30.77% |
| 2019 | -78.79 Million AUD | -3170.99% |
| 2018 | -2.4 Million AUD | 5.68% |
| 2017 | -2.55 Million AUD | 13.76% |
| 2016 | -2.96 Million AUD | 59.59% |
| 2015 | -7.32 Million AUD | -3998.45% |
| 2014 | 188.01 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -33.26 Million AUD | 0.0% |
| 2024 FY | -17.58 Million AUD | 68.6% |
| 2024 Q4 | -17.58 Million AUD | 0.0% |
| 2023 FY | -55.99 Million AUD | -43.36% |
| 2023 Q4 | -55.99 Million AUD | 0.0% |
| 2023 Q2 | -83.53 Million AUD | 0.0% |
| 2022 Q4 | -39.05 Million AUD | 0.0% |
| 2022 Q2 | -54.2 Million AUD | 0.0% |
| 2022 FY | -39.05 Million AUD | 44.43% |
| 2021 FY | -70.28 Million AUD | 31.8% |
| 2021 Q4 | -70.28 Million AUD | 0.0% |
| 2021 Q2 | -84.39 Million AUD | 0.0% |
| 2020 Q4 | -103.04 Million AUD | 0.0% |
| 2020 FY | -103.04 Million AUD | -30.77% |
| 2020 Q2 | -70 Million AUD | 0.0% |
| 2019 Q4 | -78.79 Million AUD | 0.0% |
| 2019 FY | -78.79 Million AUD | -3170.99% |
| 2019 Q2 | -9.93 Million AUD | 0.0% |
| 2018 Q2 | -6 Million AUD | 0.0% |
| 2018 FY | -2.4 Million AUD | 5.68% |
| 2018 Q4 | -2.4 Million AUD | 0.0% |
| 2017 Q2 | -5.02 Million AUD | 0.0% |
| 2017 Q4 | -2.55 Million AUD | 0.0% |
| 2017 FY | -2.55 Million AUD | 13.76% |
| 2016 Q2 | -5.22 Million AUD | 0.0% |
| 2016 Q4 | -2.96 Million AUD | 0.0% |
| 2016 FY | -2.96 Million AUD | 59.59% |
| 2015 Q4 | 46.92 Thousand AUD | 0.0% |
| 2015 FY | -7.32 Million AUD | -3998.45% |
| 2014 FY | 188.01 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AdAlta Limited | -845.17 Thousand AUD | -1980.225% |
| Acrux Limited | -1.45 Million AUD | -1105.864% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 77.831% |
| BTC Health Limited | -2.02 Million AUD | -769.444% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | -475.876% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 87.12% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 90.392% |
| Biome Australia Limited | -1.56 Million AUD | -1024.995% |
| Hexima Limited | -2.22 Million AUD | -689.749% |
| Immutep Limited | -122.18 Million AUD | 85.611% |
| Memphasys Limited | 4.13 Million AUD | 525.149% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | -2.852% |
| Noxopharm Limited | -2.31 Million AUD | -657.847% |
| Prescient Therapeutics Limited | -10.16 Million AUD | -73.0% |
| Race Oncology Limited | -17.18 Million AUD | -2.284% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 5.349% |
| Starpharma Holdings Limited | -19.83 Million AUD | 11.348% |
| Tissue Repair Ltd | -16.44 Million AUD | -6.937% |
| Biotron Limited | -386.06 Thousand AUD | -4453.99% |
| Alterity Therapeutics Limited | -12.47 Million AUD | -40.879% |
| CSL Limited | 15.76 Billion AUD | 100.112% |
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 6.97% |
| Anatara Lifesciences Ltd | -982.1 Thousand AUD | -1690.181% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -2377.81% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 446.958% |
| Patrys Limited | -2.24 Million AUD | -684.657% |
| Orthocell Limited | -19.92 Million AUD | 11.761% |
| Imugene Limited | -91.56 Million AUD | 80.798% |
| PYC Therapeutics Limited | -65.76 Million AUD | 73.265% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | -178.019% |
| Cynata Therapeutics Limited | -6.2 Million AUD | -183.325% |
| Arovella Therapeutics Limited | -12.71 Million AUD | -38.28% |
| Nanollose Limited | -96.22 Thousand AUD | -18171.236% |
| Invex Therapeutics Ltd | -6.02 Million AUD | -191.806% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | -254.885% |
| Amplia Therapeutics Limited | -1.82 Million AUD | -864.114% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | -1319.684% |
| Nyrada Inc. | -4.76 Million AUD | -268.633% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 83.381% |
| Dimerix Limited | -21.99 Million AUD | 20.054% |
| PharmAust Limited | -9.71 Million AUD | -80.989% |
| AnteoTech Limited | -5 Million AUD | -251.523% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | -417.691% |
| Avecho Biotechnology Limited | -5.32 Million AUD | -229.906% |
| Actinogen Medical Limited | -9.13 Million AUD | -92.533% |
| Immuron Limited | -11.48 Million AUD | -53.098% |
| Argenica Therapeutics Limited | -15.91 Million AUD | -10.487% |